Prices delayed by at least 15 minutes | Print


ADDEX N (ADXN)

Sell: 0.115 CHF|Buy: 0.12 CHF|Change: 0.01 (-6.50%)

Open 

0.1125 CHF


Previous close 

0.123 CHF


Trade high 

0.126 CHF


Volume 

364,591


Year high 

0.26 CHF


Year low 

0.04 CHF


Dividend yield 

-


Market capitalisation 

14.75 mn CHF


P/E ratio 

-


ISIN 

CH0029850754


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 25/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
ADDEX N- 6.50
More...

Company profile

Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.